Vulnerabilidad clínico-funcional del anciano em polifarmacia según critérios Beers

Abstract

Objective: To evaluate the clinical and functional vulnerability in cardiogeriatrics by valuing the implication of polypharmacy as the Beers Criterion in the functionality of the elderly patient. Methods: Quantitative cross- sectional study conducted with the application of the questionnaire "Clinical-Functional Vulnerability Index 20 (IVCF-20)" to be answered by cardiogeriatric patients using four or more simultaneous medications. Results: 30% of cardiogeriatric participants using polypharmacy according to Beer's criterion are robust compared to ivcf-20, 42% are moderate and 28% are of high vulnerability. Since 40.58% of participants between 60 and 75 years of age are robust, 42.86% of participants between 75 and 84 years of age have moderate clinical and functional vulnerability and 83% of participants aged 85 years or older have high vulnerability. The present study also showed that the comparison between the IVCF of participants from public or private medical care was not relevant (p<0.05), as well as female and male. Conclusion: The Functional Clinical Vulnerability Index-20 is a multidimensional evaluation method of quick and easy application that allows identifying the main factors that lead to the fragility of the elderly, and the Beers Criterion contributes to this reduction of damage in the functionality of the cardiogeriatric population, through the appropriate polypharmacy.